Author response for 'Lower risk of cardiovascular events and death associated with initiation of SGLT ‐2 inhibitors versus sulphonylureas – Analysis from the CVD‐REAL 2 study'

Autor: null Su‐Yen Goh, null Mikhail N Kosiborod, null Carolyn S. P. Lam, null Matthew A. Cavender, null Shun Kohsaka, null Anna Norhammar, null Kare I Birkeland, null Reinhard W Holl, null Dídac Mauricio, null Navdeep Tangri, null Jonathan E Shaw, null Marcus Thuresson, null Peter Fenici, null Dae Jung Kim, null M Kosiborod, null MA Cavender, null JP Wilding, null K Khunti, null A Norhammar, null K Birkeland, null ME Jørgensen, null RW Holl, null CSP Lam, null HL Gulseth, null B Carstensen, null E Bollow, null J Franch‐Nadal, null LAG Rodríguez, null A Karasik, null N Tangri, null S Kohsaka, null DJ Kim, null J Shaw, null S Arnold, null SY Goh, null CE Chiang, null JG Eriksson, null F Zaccardi, null P Fenici, null J Bodegård, null H Chen, null F Surmont, null R Kendrick, null W Belli, null ET Wittbrodt, null M Saathoff, null Y Noguchi, null D Tan, null M Williams, null HW Lee, null M Greenbloom, null O Kaidanovich‐Beilin, null K Andersson‐Sundell, null KK Yeo, null YM Bee, null J Khoo, null A Koong, null YH Lau, null F Gao, null WB Tan, null HA Kadir, null KH Ha, null J Lee, null G Chodick, null CM Cohen, null R Whitlock, null LC Soriano, null JA Menzin, null M Guthrie, null J Ilomaki, null D Magliano, null F Hoti, null S Christopher, null M Vehkala, null the CVD‐REAL Investigators and Study Group, null Cantero OF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2b9ef53181c174bb6291452d0db1b4b
https://doi.org/10.1111/dom.15092/v2/response1

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Autor: Kosiborod, Mikhail, Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Birkeland, Kåre I., Jørgensen, Marit Eika, Thuresson, Marcus, Arya, Niki, Bodegård, Johan, Hammar, Niklas, Fenici, Peter, CVD-REAL Investigators and Study Group*

Publikováno v: Circulation; 7/18/2017, Vol. 136 Issue 3, p249-259, 11p

Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".

Autor: Kosiborod, Mikhail, Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Holl, Reinhard W., Norhammar, Anna, Birkeland, Kåre I., Jørgensen, Marit Eika, Thuresson, Marcus, Arya, Niki, Bodegård, Johan, Hammar, Niklas, Fenici, Peter, CVD-REAL Investigators and Study Group

Publikováno v: Circulation; 2/27/2018, Vol. 137 Issue 9, p989-991, 3p

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL.

Autor: Cavender, Matthew A¹ (AUTHOR), Norhammar, Anna² (AUTHOR), Birkeland, Kåre I³ (AUTHOR), Jørgensen, Marit Eika⁴ (AUTHOR), Wilding, John P⁵ (AUTHOR), Khunti, Kamlesh⁶ (AUTHOR), Fu, Alex Z⁷ (AUTHOR), Bodegård, Johan⁸ (AUTHOR), Blak, Betina T⁹ (AUTHOR), Wittbrodt, Eric¹⁰ (AUTHOR), Thuresson, Marcus¹¹ (AUTHOR), Fenici, Peter¹² (AUTHOR), Hammar, Niklas¹³ (AUTHOR), Kosiborod, Mikhail¹⁴ (AUTHOR), CVD-REAL Investigators and Study Group (CORPORATE AUTHOR)

Publikováno v: Journal of the American College of Cardiology (JACC). Jun2018, Vol. 71 Issue 22, p2497-2506. 10p.